# Superficial Temporal Artery to Middle Cerebral Artery (STA-MCA) bypass: How I do it

**Authors:** Paolo Palmisciano, Bruno Vernile, Sudhakar Vadivelu, Mario Zuccarello

PMC · DOI: 10.1007/s00701-026-06799-2 · Acta Neurochirurgica · 2026-02-17

## TL;DR

This paper explains the step-by-step surgical technique for a specific brain bypass procedure used to treat complex brain conditions.

## Contribution

The paper introduces a detailed and systematic approach to performing STA-MCA bypass surgery with a focus on technical nuances and safety.

## Key findings

- A stepwise operative strategy for STA-MCA bypass is described with an emphasis on vessel preparation and microanastomosis.
- Intraoperative patency assessment and meticulous planning are highlighted as essential for successful outcomes.
- Technical nuances and postoperative management are emphasized to avoid complications.

## Abstract

The superficial temporal artery–middle cerebral artery (STA–MCA) bypass remains a key extracranial–intracranial revascularization technique for moyamoya disease, complex aneurysms, and symptomatic steno-occlusive pathology not amenable to endovascular treatment. Effective bypass requires detailed knowledge of STA and MCA anatomy, comprehensive preoperative imaging, and meticulous microsurgical planning. We describe a stepwise operative strategy including donor and recipient vessel preparation, microanastomosis, and intraoperative patency assessment. Technical nuances, complication avoidance, and postoperative management are emphasized. This report outlines essential principles for safe and durable STA–MCA bypass revascularization.

The online version contains supplementary material available at 10.1007/s00701-026-06799-2.

## Linked entities

- **Diseases:** moyamoya disease (MONDO:0016820)

## Full-text entities

- **Diseases:** cerebral atrophy (MESH:D001284), aneurysms (MESH:D000783), hemodynamic impairment (MESH:D060825), skull base tumors (MESH:D019292), vessel occlusion (MESH:C536223), ischemic disease (MESH:D017202), blood (MESH:D006402), ICA steno-occlusive disease (MESH:D001157), Hyperperfusion syndrome (MESH:D013577), cerebral aneurysms (MESH:D002532), thrombosis (MESH:D013927), subdural collections (MESH:D002292), cognitive dysfunction (MESH:D003072), vasospasm (MESH:D020301), Seizures (MESH:D012640), stenosis (MESH:D003251), ischemia (MESH:D007511), paralysis (MESH:D010243), Moyamoya disease (MESH:D009072), speech impairment (MESH:D013064), hemorrhagic (MESH:D006470), infarction (MESH:D007238)
- **Chemicals:** ICG (MESH:D007208), EC-IC (-), saline (MESH:D012965), papaverine (MESH:D010208), aspirin (MESH:D001241), methylene blue (MESH:D008751)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12916888/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12916888/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12916888/full.md

---
Source: https://tomesphere.com/paper/PMC12916888